n/a
Article Publish Status: FREE
Abstract Title:

Urtica dioica agglutinin (UDA) as a potential candidate for inhibition of SARS-CoV-2 Omicron variants: In silico prediction and experimental validation.

Abstract Source:

Phytomedicine. 2023 Mar ;111:154648. Epub 2023 Jan 6. PMID: 36681052

Abstract Author(s):

Fatemeh Sabzian-Molaei, Seyedrafi Hosseini, Atefeh Alipour, Hajarossadat Ghaderi, Fatemeh Fotouhi-Chahouki, Amin Hadi, Hosein Shahsavarani

Article Affiliation:

Fatemeh Sabzian-Molaei

Abstract:

BACKGROUND: The high number of mutations and consequent structure modifications in a Receptor-Binding Domain (RBD) of the spike protein of the Omicron variant of SARS-CoV-2 increased concerns about evading neutralization by antibodies induced by previous infection or vaccination. Thus, developing novel drugs with potent inhibitory activity can be considered an alternative for treating this highly transmissible variant. Considering that Urtica dioica agglutinin (UDA) displays antiviral activity against SARS-CoV-2, the potency of this lectin to inhibit the Receptor Binding Domain of the Omicron variant (RBD) was examined in this study.

PURPOSE: This study examines how UDA inhibits the Omicron variant of SARS-CoV-2 by blocking its RBD, using a combination of in silico and experimental methods.

METHODS: To investigate the interaction between UDA and RBD, the CLUSPRO 2.0 web server was used to dock the RBD-UDA complex, and molecular dynamics simulations were performed by the Gromacs 2020.2 software to confirm the stability of the selected docked complex. Finally, the binding affinity (ΔG) of the simulation was calculated using MM-PBSA. In addition, ELISA and Western blot tests were used to examine UDA's binding to RBD.

RESULTS: Based on the docking results, UDA forms five hydrogen bonds with the RBDactive site, which contains mutated residues Tyr501, Arg498, Arg493, and His505. According to MD simulations, the UDA-RBDcomplex is stable over 100 ns, and its average binding energy during the simulation is -87.201 kJ/mol. Also, the ELISA test showed that UDA significantly binds to RBD, and by increasing the concentration of UDA protein, the attachment to RBDbecame stronger. In Western blotting, RBDwas able to attach to and detect UDA.

CONCLUSION: This study indicates that UDA interaction with RBDprevents virus attachment to Angiotensin-converting enzyme 2 (ACE2) and, therefore, its entry into the host cell. Altogether, UDA exhibited a significant suppression effect on the Omicron variant and can be considered a new candidate to improve protection against severe infection of this variant.

Study Type : In Vitro Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.